Landscape Capital Management L.L.C. Buys 111,894 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Landscape Capital Management L.L.C. grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 43.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 367,935 shares of the company’s stock after purchasing an additional 111,894 shares during the period. Landscape Capital Management L.L.C. owned approximately 0.10% of LifeStance Health Group worth $2,576,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Intech Investment Management LLC bought a new position in shares of LifeStance Health Group during the third quarter valued at approximately $311,000. Jennison Associates LLC grew its position in LifeStance Health Group by 9.5% in the 3rd quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after acquiring an additional 184,896 shares during the last quarter. Principal Financial Group Inc. grew its position in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after acquiring an additional 235,316 shares during the last quarter. Park Edge Advisors LLC purchased a new stake in LifeStance Health Group in the third quarter worth $73,000. Finally, SG Americas Securities LLC lifted its position in shares of LifeStance Health Group by 406.4% during the third quarter. SG Americas Securities LLC now owns 54,532 shares of the company’s stock worth $382,000 after purchasing an additional 43,763 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Analyst Ratings Changes

LFST has been the topic of a number of research analyst reports. Barclays upped their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. UBS Group dropped their price objective on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $8.50.

LifeStance Health Group Trading Up 1.2 %

NASDAQ LFST opened at $7.31 on Friday. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $9.20. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.80 billion, a PE ratio of -28.12 and a beta of 1.24. The company has a fifty day moving average of $7.01 and a 200 day moving average of $6.27.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The firm had revenue of $312.70 million during the quarter, compared to analyst estimates of $302.25 million. During the same period in the previous year, the firm earned ($0.17) EPS. The business’s quarterly revenue was up 18.9% on a year-over-year basis. Research analysts forecast that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current year.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.